Search

Concord Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 14.90 0.00  | 0.00% -35.22% 28.36 11.71
BSE Price: Oct 17, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 17, 2019 14.90 0.00 0.00% 14.90 14.90 11 14.90 - 14.90
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 478 P/B: 0.50 NSE Code:
52-Week Range: R 13.50 - 26.00 Dividend Yield: 0.00% BSE Code: 538965
TTM EPS: R 0.53 Book Value: R 29.62 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Concord Drugs -34.07 -16.29 -33.78 -35.22 -36.57 - -
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -7.18 -1.74 7.20
Net Profit 25.58 -38.49 3.74
EPS 25.59 -40.14 2.05
Book Value 19.84 12.30 11.07
Average
Operating Margin 7.79 9.04 12.46
Net Margin 0.85 0.58 1.38
Return on Networth 1.92 1.51 4.45
Return on Investment 6.17 7.50 9.95
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -7.35 2.14 -7.35
Operating Profit 33.65 -5.35 33.65
Net Profit -34.63 4.69 -34.63
EPS -41.24 -5.90 -41.24
TTM
Revenue 0.58 10.31 0.58
Operating Profit -1.47 6.80 -1.47
Net Profit 1.47 152.75 1.47
EPS -1.85 151.34 -1.85
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Concord Drugs 11.71 48.38 0.41 0.85 1.92 0.50 28.36
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 14, 2019 S Koni Reddy  Buy Conversion of Security 178,000 23.00 40.94
May 14, 2019 S Koni Reddy  Sell Conversion of Security 178,000 23.00 40.94
May 14, 2019 S Manoj Kumar Reddy  Buy Conversion of Security 214,000 23.00 49.22
May 14, 2019 S Manoj Kumar Reddy  Sell Conversion of Security 214,000 23.00 49.22
May 14, 2019 S Nagi Reddy  Buy Conversion of Security 290,000 23.00 66.70
News & Announcements
Contact Information

Company: Concord Drugs Ltd.

Address: Survey No.249, Brahmanapally Village, Hayatnagar Mandal, R R Dist, Hyderabad, Telangana - 501511 | Phone: 91-040 24036379/24037763

Email: [email protected]

Website: www.concorddrugs.in

Registrar & Transfer Agent: Aarthi Consultants Pvt Ltd

Address: 1-2-285 , Domalaguda,,Hyderabad, 1-2-285, Domalaguda | Phone: 040-7642217/7634445 | Fax: 040-7632184

Essential checks
Altman Z-Score
1.25
Piotroski F-Score
Underlying data
not available
Modified C-Score
Underlying data
not available
3-Years Price to Earnings
28.36
3-Years Price to Book
0.50
Earnings Yield
EBIT / Enterprise value
10.11%
PEG
Price / Earnings to growth ratio
-0.61
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59